Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 11374411)

Published in Transplantation on April 27, 2001

Authors

A Piazza1, E Poggi, L Borrelli, S Servetti, P I Monaco, O Buonomo, M Valeri, N Torlone, D Adorno, C U Casciani

Author Affiliations

1: Consiglio Nazionale delle Ricerche, Institute of Tissue Typing, Unit of Rome, Italy.

Articles citing this

Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol (2008) 1.11

Chronic alloantibody mediated rejection. Semin Immunol (2011) 0.87

Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques. Am J Transplant (2012) 0.85

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. Transpl Immunol (2012) 0.84

Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program. J Nephropathol (2014) 0.82

Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation. Clin Dev Immunol (2013) 0.82

The link between major histocompatibility complex antibodies and cell proliferation. Transplant Rev (Orlando) (2011) 0.79

Kidney transplantation in sensitized recipients; a single center experience. J Korean Med Sci (2009) 0.79

B cells with regulatory properties in transplantation tolerance. World J Transplant (2015) 0.78

The role of antibodies in transplantation. Transplant Rev (Orlando) (2009) 0.78

Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol (2014) 0.77

Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. Wien Klin Wochenschr (2006) 0.77

Flow cytometry and solid organ transplantation: a perfect match. Immunol Invest (2014) 0.76

Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets. Cureus (2015) 0.76

Unraveling the Role of Allo-Antibodies and Transplant Injury. Front Immunol (2016) 0.75

Different impact of pretransplant anti-HLA antibodies detected by Luminex in highly sensitized renal transplanted patients. Biomed Res Int (2013) 0.75

Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation. Balkan Med J (2013) 0.75

Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipients. Biomed Res Int (2014) 0.75

[Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions]. Wien Klin Wochenschr (2006) 0.75

Articles by these authors

Radiological research in Europe: a bibliometric study. Eur Radiol (2002) 2.20

Fusion of the human gene for the polyubiquitination coeffector UEV1 with Kua, a newly identified gene. Genome Res (2000) 2.19

Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis. Ann Thorac Surg (1996) 1.61

Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53

Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol (1999) 1.43

One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol (1999) 1.39

Comparison between intercostal and diaphragmatic flap in the surgical treatment of early bronchopleural fistula. Eur J Cardiothorac Surg (1997) 1.39

Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother (1996) 1.32

Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol (1986) 1.20

PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene (2001) 1.11

Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells. Cell Immunol (1989) 1.02

Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol (1983) 1.01

The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein. J Biol Chem (2001) 0.95

Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplant Proc (2004) 0.93

Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer. Cancer Immunol Immunother (2000) 0.93

Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology (1999) 0.91

Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer (1997) 0.89

Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience. Ren Fail (2001) 0.89

CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood (2001) 0.88

Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated. Cancer Biother Radiopharm (1998) 0.87

Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother (1994) 0.87

Reconstruction of the nasal dorsum with autologous rib cartilage. Ann Plast Surg (2006) 0.87

Comparison of epidural, continuous femoral block and intraarticular analgesia after anterior cruciate ligament reconstruction. Acta Anaesthesiol Scand (2003) 0.87

Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Horm Metab Res (2010) 0.86

Comparative study of oncoplastic versus non-oncoplastic breast conserving surgery in a group of 211 breast cancer patients. Eur Rev Med Pharmacol Sci (2016) 0.86

Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens (2004) 0.86

Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects. Ric Clin Lab (1989) 0.86

Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients. Eur J Cancer (1991) 0.86

Pregnancy in renal transplantation. Clinical aspects. Clin Exp Obstet Gynecol (1984) 0.85

The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. Cancer Immunol Immunother (1998) 0.85

Prevalence of thermotolerant Campylobacter in partridges (Perdix perdix). Lett Appl Microbiol (2009) 0.85

Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother (1999) 0.85

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer. Breast Cancer Res Treat (2001) 0.84

HLA-B5 and Behçet's disease. Tissue Antigens (1979) 0.84

The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl (1985) 0.84

Late symptomatic venous stenosis in three hemodialysis patients without previous central venous catheters. Artif Organs (2000) 0.84

Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients. Anticancer Res (1996) 0.83

Comparison between HLA-DR serologic typing and oligotyping in kidney transplant: a single center experience. Transplant Proc (1993) 0.83

Sentinel lymphadenectomy in cutaneous melanoma. Tumori (2002) 0.83

Use of mycophenolate mofetil in liver transplantation: a literature review. Transplant Proc (2005) 0.83

Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg (1998) 0.83

Activation of 5-lipoxygenase and related cell membrane lipoperoxidation in hemodialysis patients. J Am Soc Nephrol (1999) 0.83

Pattern visual evoked potentials and brainstem auditory evoked responses in uremic patients. Acta Neurol Belg (1982) 0.83

Gigantomastia and breast lumps in a kidney transplant recipient. Transplant Proc (1999) 0.82

Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. Transplant Proc (1999) 0.82

A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis. Int Angiol (1989) 0.82

Prospective randomized trial of submucosal hemorrhoidectomy with radiofrequency bistoury vs. conventional Parks' operation. Tech Coloproctol (2004) 0.82

X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: report on new mutation of the DAX-1 gene in two siblings. J Endocrinol Invest (2006) 0.82

A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation (1999) 0.81

Autologous cartilage graft rhinoplasties. Aesthetic Plast Surg (2006) 0.81

Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Cancer Res (1996) 0.81

Marginal donors in liver transplantation. Transplant Proc (2004) 0.81

Immunosorbent treatment in myasthenia gravis. Prog Clin Biol Res (1990) 0.80

Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil. Eur J Clin Invest (2006) 0.80

Radiofrequency fistulectomy vs. diathermic fistulotomy for submucosal fistulas: a randomized trial. Eur Rev Med Pharmacol Sci (2004) 0.80

Echographic valuation of risk factors for cardiovascular disease in patients with renal transplantation. Transplant Proc (2001) 0.80

The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. Cancer Biother Radiopharm (2000) 0.80

Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Exp Neurol (1996) 0.80

Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking). Tissue Antigens (2010) 0.80

Usefulness of the Nd:YAG laser in parenchyma-sparing resection of pulmonary nodular lesions. Tumori (1994) 0.80

Combined general and epidural anesthesia with ropivacaine for renal transplantation. Minerva Anestesiol (2003) 0.80

Cardiac function and oxygen balance in septic patients during continuous hemofiltration. Blood Purif (1998) 0.79

Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. Int J Immunopathol Pharmacol (2010) 0.79

Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. Neuroimmunomodulation (1998) 0.79

Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes. Diabetologia (1986) 0.79

Flow cytometric analysis of antidonor-specific antibodies in liver transplant. Transplant Proc (1997) 0.79

Immunological aspects of chronic uremia. Kidney Int Suppl (1978) 0.79

Rhomboid flap procedure for pilonidal sinus: results from 67 cases. Int J Colorectal Dis (1998) 0.79

A biomonitoring study assessing the residual biological effects of pollution caused by the HAVEN wreck on marine organisms in the Ligurian Sea (Italy). Arch Environ Contam Toxicol (2007) 0.79

IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. Cancer Biother Radiopharm (1997) 0.79

Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids. Transplant Proc (1999) 0.79

Myasthenia gravis (MG) treatment with immunoadsorbent columns. Biomater Artif Cells Immobilization Biotechnol (1991) 0.79

Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen. J Clin Oncol (1996) 0.79

En bloc minimal laser resection for T3-chest wall lung cancer in patients with poor pulmonary function. Chest (1996) 0.79

Nuclear steroid receptors and dysplasia in adenomatous polyps of the colon as markers of high risk for malignant transformation. Cancer Detect Prev (1986) 0.79

Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron (1984) 0.79

High-pressure perfusion versus gravity perfusion in liver harvesting: results from a prospective randomized study. Transplant Proc (2001) 0.78

HLA antigens and neuroleptic response in clinical subtypes of schizophrenia. J Psychiatr Res (1989) 0.78

Primary malignant fibrous histiocytoma of storiform-pleomorphic type: a case report of an ano-rectal localization. Tumori (1984) 0.78

Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm (1996) 0.78

Renal allograft immune response is influenced by patient and donor cytokine genotypes. Transplant Proc (2007) 0.78